Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid

Seán Shaw, Merouane Bencherif, Mario B. Marrero

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

The molecular mechanisms of α7 nicotinic acetylcholine receptor (nAChR)-mediated neuroprotection remain unclear. In this study we provide evidence that nicotine stimulation of α7 nAChR transduces signals to phosphatidylinositol 3-kinase and Akt via Janus kinase 2 (JAK2) in a cascade, which results in neuroprotection. Exposure to β-amyloid results in the activation of the apoptotic enzyme caspase-3 and cleavage of the DNA-repairing enzyme poly-(ADP-ribose) polymerase. This cascade is inhibited by nicotine through JAK2 activation, and these effects are blocked by preincubation with the JAK2-specific inhibitor AG-490. We also found that pretreatment of cells with angiotensin II blocks the nicotine-induced activation of JAK2 via the AT2 receptor and completely prevents α7 nAChR-mediated neuroprotective effects further suggesting a pivotal role for JAK2. These findings identify novel mechanisms of receptor interactions relevant to neuronal viability and suggest novel therapeutic strategies to optimize neuroprotection.

Original languageEnglish (US)
Pages (from-to)44920-44924
Number of pages5
JournalJournal of Biological Chemistry
Volume277
Issue number47
DOIs
StatePublished - Nov 22 2002

Fingerprint

Janus Kinase 2
Nicotinic Receptors
Amyloid
Nicotine
Chemical activation
Phosphatidylinositol 3-Kinase
DNA Cleavage
Enzyme Activation
Poly(ADP-ribose) Polymerases
Neuroprotective Agents
Enzymes
Caspase 3
Angiotensin II
Cells
Neuroprotection
DNA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid. / Shaw, Seán; Bencherif, Merouane; Marrero, Mario B.

In: Journal of Biological Chemistry, Vol. 277, No. 47, 22.11.2002, p. 44920-44924.

Research output: Contribution to journalArticle

Shaw, Seán ; Bencherif, Merouane ; Marrero, Mario B. / Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 47. pp. 44920-44924.
@article{3c73e203b149481b835a38877a62552b,
title = "Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid",
abstract = "The molecular mechanisms of α7 nicotinic acetylcholine receptor (nAChR)-mediated neuroprotection remain unclear. In this study we provide evidence that nicotine stimulation of α7 nAChR transduces signals to phosphatidylinositol 3-kinase and Akt via Janus kinase 2 (JAK2) in a cascade, which results in neuroprotection. Exposure to β-amyloid results in the activation of the apoptotic enzyme caspase-3 and cleavage of the DNA-repairing enzyme poly-(ADP-ribose) polymerase. This cascade is inhibited by nicotine through JAK2 activation, and these effects are blocked by preincubation with the JAK2-specific inhibitor AG-490. We also found that pretreatment of cells with angiotensin II blocks the nicotine-induced activation of JAK2 via the AT2 receptor and completely prevents α7 nAChR-mediated neuroprotective effects further suggesting a pivotal role for JAK2. These findings identify novel mechanisms of receptor interactions relevant to neuronal viability and suggest novel therapeutic strategies to optimize neuroprotection.",
author = "Se{\'a}n Shaw and Merouane Bencherif and Marrero, {Mario B.}",
year = "2002",
month = "11",
day = "22",
doi = "10.1074/jbc.M204610200",
language = "English (US)",
volume = "277",
pages = "44920--44924",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "47",

}

TY - JOUR

T1 - Janus kinase 2, an early target of α7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid

AU - Shaw, Seán

AU - Bencherif, Merouane

AU - Marrero, Mario B.

PY - 2002/11/22

Y1 - 2002/11/22

N2 - The molecular mechanisms of α7 nicotinic acetylcholine receptor (nAChR)-mediated neuroprotection remain unclear. In this study we provide evidence that nicotine stimulation of α7 nAChR transduces signals to phosphatidylinositol 3-kinase and Akt via Janus kinase 2 (JAK2) in a cascade, which results in neuroprotection. Exposure to β-amyloid results in the activation of the apoptotic enzyme caspase-3 and cleavage of the DNA-repairing enzyme poly-(ADP-ribose) polymerase. This cascade is inhibited by nicotine through JAK2 activation, and these effects are blocked by preincubation with the JAK2-specific inhibitor AG-490. We also found that pretreatment of cells with angiotensin II blocks the nicotine-induced activation of JAK2 via the AT2 receptor and completely prevents α7 nAChR-mediated neuroprotective effects further suggesting a pivotal role for JAK2. These findings identify novel mechanisms of receptor interactions relevant to neuronal viability and suggest novel therapeutic strategies to optimize neuroprotection.

AB - The molecular mechanisms of α7 nicotinic acetylcholine receptor (nAChR)-mediated neuroprotection remain unclear. In this study we provide evidence that nicotine stimulation of α7 nAChR transduces signals to phosphatidylinositol 3-kinase and Akt via Janus kinase 2 (JAK2) in a cascade, which results in neuroprotection. Exposure to β-amyloid results in the activation of the apoptotic enzyme caspase-3 and cleavage of the DNA-repairing enzyme poly-(ADP-ribose) polymerase. This cascade is inhibited by nicotine through JAK2 activation, and these effects are blocked by preincubation with the JAK2-specific inhibitor AG-490. We also found that pretreatment of cells with angiotensin II blocks the nicotine-induced activation of JAK2 via the AT2 receptor and completely prevents α7 nAChR-mediated neuroprotective effects further suggesting a pivotal role for JAK2. These findings identify novel mechanisms of receptor interactions relevant to neuronal viability and suggest novel therapeutic strategies to optimize neuroprotection.

UR - http://www.scopus.com/inward/record.url?scp=0346460961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346460961&partnerID=8YFLogxK

U2 - 10.1074/jbc.M204610200

DO - 10.1074/jbc.M204610200

M3 - Article

C2 - 12244045

AN - SCOPUS:0346460961

VL - 277

SP - 44920

EP - 44924

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 47

ER -